Business Context and Reporting Period
This Form 8-K Current Report was filed by Second Sight Medical Products, Inc. on October 22, 2018, covering events occurring on October 18, 2018. The filing discloses a material definitive agreement and unregistered sales of equity securities. Note: The request metadata references "Vivani Medical, Inc.," but the filing text explicitly identifies the registrant as "Second Sight Medical Products, Inc."
Key Financial Metrics
- Transaction Type: Private placement of common stock.
- Shares Issued: 2,467,727 shares.
- Price Per Share: $1.62 (last reported sale price on the effective date).
- Gross Proceeds: Approximately $3,997,718.
- Transaction Costs: No placement agent or investment banking fees were incurred.
- Warrants/Discounts: None provided.
Material Changes
The Company entered into a Securities Purchase Agreement with entities beneficially owned by Gregg Williams, the Chairman of the Board of Directors. This transaction represents a capital raise event rather than an operational performance change. The shares were issued pursuant to an exemption from registration under Rule 506 of Regulation D and Section 4(a)(2) of the Securities Act of 1933.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard securities law disclosures. The primary contingency noted is that the shares are unregistered and may not be offered or sold in the United States absent registration or an applicable exemption. The investors represented they are acquiring the shares for investment purposes only and not for resale.
Investor Verification Checklist
- Verify the exact number of shares issued (2,467,727) and the total gross proceeds ($3,997,718) against the attached Securities Purchase Agreement (Exhibit 10.1).
- Confirm the identity of the purchasers as entities beneficially owned by Chairman Gregg Williams.
- Review the press release dated October 22, 2018 (Exhibit 99.1) for any additional context regarding the use of proceeds.
- Ensure the company name is correctly identified as Second Sight Medical Products, Inc., not Vivani Medical, Inc.